Spots Global Cancer Trial Database for Identification of Biomarkers for Patients With Vascular Anomalies

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Identification of Biomarkers for Patients With Vascular Anomalies

Official Title: Identification of Biomarkers for Patients With Vascular Anomalies

Study ID: NCT03001180

Conditions

Vascular Anomaly

Generalized Lymphatic Anomaly

Kaposiform Hemangioendothelioma

Kaposiform Lymphangiomatosis

Gorham-Stout Disease

Klippel Trenaunay Syndrome

Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi

Interventions

Study Description

Brief Summary: The study will use blood (serum and plasma) and tissue obtained from participants undergoing prescribed surgical resection of vascular anomalies of interest proposed in this study. The study will also use blood (serum and plasma) and tissue collected and stored in a tissue bank maintained by the Department of Hematology/Oncology.

Detailed Description: While vascular anomalies are rare diseases, they can be life-threatening and devastating to affected children and their families. Advances in diagnosis, monitoring and therapies will be significantly improved if non-invasive biomarkers that are sensitive and specific can be identified. Obtaining a tissue biopsy to help in diagnosis can actually worsen the disease and so identification of specific blood biomarkers is highly desirable. Studies will measure angiogenic factors in serum and plasma samples at baseline and on therapy. Tissue removed during surgical resection or blood removed prior to sclerotherapy will be used to obtain cells and tissue for the assessment of where biomarkers are coming from and to identify disease-causing pathways for new therapeutic targeting.